Below are recent news releases and media coverage concerning BioMedEcon events, research and case examples of client projects.

News
BioMedEcon receivest jointly-funded grant from the American Association of Allergy, Asthma, and Immunotherapy (AAAAI) and the American College of Allergy, Asthma, and Immunology (ACAAI) to examine the comparative effectiveness of allergen-specific immunotherapy versus symptomatic drug treatment among adults with allergic rhinitis.

In two previously-conducted comparative effectiveness studies, BioMedEcon demonstrated that children with newly diagnosed allergic rhinitis who subsequently received allergen-specific immunotherapy used significantly fewer health care resources and incurred significantly lower costs than children with allergic rhinitis who did not receive allergen-specific immunotherapy. View Papers (1) (2)

A grant, jointly funded by the AAAAI and ACAAI, extends this research to adults.  Findings will be presented at the 2011 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. San Francisco, CA; March 18-22, 2011. See additional information under "Events" below.

Events
March 18-22, 2011
San Francisco, CA
BioMedEcon delivers multiple presentations at the 2011 Annual Meeting of the American Academy of Allergy Asthma & Immunology.
Invited Symposium Presentation, Saturday, March 19, 2011
Invited Forum Presentation, Sunday, March 20, 2011
Oral Presentation , Saturday, March 19, 2011
Featured Poster Session (“The Best of IRSOC”), Sunday, March 20

March 2-5, 2011
Dallas, TX
BioMedEcon presents several posters at the American Society for Clinical Pharmacology and Therapeutics 2011 Annual Meeting  
More Info

February 16-19, 2011
London, UK
BioMedEcon presents at the 4th International Conference on Advanced Technologies & Treatments for Diabetes.
Oral Session PDF, Poster Presentation



Press Releases
1/11/2010 – Allergy Vaccinations Reduce Children’s Healthcare Costs by One-third. Press release by the American College of Allergy Asthma and Immunology (ACAAI). View full article

12/11/2008 - BioMedEcon’s Cheryl Hankin Appointed to Prestigious Boston University School of Public Health Advisory Committee. View full article >

10/15/2008 - BioMedEcon Study Reveals Greater Use of Psychotropics for Treating Obsessive-Compulsive Disorder versus Depression.
View full article >

6/18/2008 - More Than Two-Thirds of Newly-Diagnosed Patients Who Are Prescribed Medications for OCD Receive Inadequate Therapy.
View full article >

6/12/2008 - BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Compared to Matched Patients with Depression. View full article >


Media Coverage
Medical News Today (www.medicalnewstoday.com). “Three shots and they're out" - allergy immunotherapy study sheds new light on when patients stop treatment. March 19, 2009. Download PDF

London, S. Immunotherapy cuts cost of care in allergic rhinitis. Pediatric News Dec 2008; 42(12): 1, 8. Download PDF

Medical News Today (www.medicalnewstoday.com). BioMedEcon reports 200% higher outpatient medical costs among patients with obsessive-compulsive disorder compared to matched patients with depression; June 15, 2008. Download PDF

Tucker M.E. Medical costs are much higher in OCD than Depression. Available at www.clinicalpsychiatrynews.com; May, 2008. Download PDF

Myshko D. The call for pharmacoeconomic data. PharmaVoice. May 2008: pp. 88-89. Download PDF

Medical News Today (www.medicalnewstoday.com). BioMedEcon reports three times higher healthcare costs among patients with obsessive-compulsive disorder compared to patients with depression. April 16, 2008. Download PDF

Drugs.Com (www.drugs.com). Study says allergy shots help children, reduce health care costs BioMedEcon study, first of its kind in us, finds allergy immunotherapy beneficial even when treatment not completed. January 11, 2008. Download PDF

Batluck A. How should cost your psoriasis decisions? Practical Dermatology. Sept 2005: 32-37. Download PDF

To access information about BioMedEcon specifically, please visit the About BioMedEcon page, where company background, employee biographies and photos are available.

Contact Information
If you are a member of the media, and would like to speak with someone at BioMedEcon or receive additional information, please contact us at media@biomedecon.com or call 650.563.9475.